AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2016 • Intra-Cellular Therapies, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionThis Amendment No. 1 to Employment Agreement (the “Amendment”), dated as of November 9, 2016, is entered into by and between Intra-Cellular Therapies, Inc. (the “Company”), and Michael Halstead (the “Executive”), for purposes of amending the terms of that certain Employment Agreement dated August 3, 2015 (the “Agreement”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2016 • Intra-Cellular Therapies, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionThis Amendment No. 1 to Employment Agreement (the “Amendment”), dated as of November 9, 2016, is entered into by and between Intra-Cellular Therapies, Inc. (the “Company”), and Kimberly Vanover (the “Executive”), for purposes of amending the terms of that certain Employment Agreement dated November 5, 2015 (the “Agreement”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2016 • Intra-Cellular Therapies, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionThis Amendment No. 1 to Employment Agreement (the “Amendment”), dated as of November 9, 2016, is entered into by and between Intra-Cellular Therapies, Inc. (the “Company”), and Robert Davis (the “Executive”), for purposes of amending the terms of that certain Employment Agreement dated November 4, 2015 (the “Agreement”).